Literature DB >> 10355844

The effects of pyruvate supplementation on body composition in overweight individuals.

D Kalman1, C M Colker, I Wilets, J B Roufs, J Antonio.   

Abstract

A 6-wk, double-blinded, placebo-controlled study was done to ascertain the effects of pyruvate supplementation (6 g/d) on body weight, body composition, and vigor and fatigue levels in healthy overweight Caucasian men and women. Twenty-six individuals were randomly assigned to a placebo group (seven men, seven women) and a pyruvate-supplemented group (three men, nine women). In addition, all subjects participated in a 3 d/wk exercise program, which consisted of a 45-60 min aerobic/anaerobic routine. After 6 wk of treatment, there was a statistically significant decrease in body weight (-1.2 kg, P<0.001), body fat (-2.5 kg, P<0.001), and percent body fat (23.0% pre versus 20.3% 6 wk post) in the pyruvate group. Furthermore, Profile of Mood States fatigue and vigor scores improved significantly for the pyruvate group (P<0.05) at 6 wk (vigor) and 4 and 6 wk (fatigue). There was no significant change in total lean body mass in the pyruvate group. The placebo group demonstrated a significant increase (P<0.05) for POMS vigor at 2 and 4 wk with no changes occurring in any of the remaining parameters measured. Thus, the ingestion of 6 g of pyruvate for 6 wk, in conjunction with mild physical activity, resulted in a significant decrease in body weight and fat mass.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10355844     DOI: 10.1016/s0899-9007(99)00034-9

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  10 in total

1.  Pyruvate induces torpor in obese mice.

Authors:  Marion Soto; Lucie Orliaguet; Michelle L Reyzer; M Lisa Manier; Richard M Caprioli; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  An evidence-based review of fat modifying supplemental weight loss products.

Authors:  Amy M Egras; William R Hamilton; Thomas L Lenz; Michael S Monaghan
Journal:  J Obes       Date:  2010-08-10

Review 3.  Progress in metabolic engineering of Saccharomyces cerevisiae.

Authors:  Elke Nevoigt
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

4.  Single sodium pyruvate ingestion modifies blood acid-base status and post-exercise lactate concentration in humans.

Authors:  Robert A Olek; Sylwester Kujach; Damian Wnuk; Radoslaw Laskowski
Journal:  Nutrients       Date:  2014-05-16       Impact factor: 5.717

5.  Pyruvate production using engineered Escherichia coli.

Authors:  Hironaga Akita; Nobutaka Nakashima; Tamotsu Hoshino
Journal:  AMB Express       Date:  2016-10-08       Impact factor: 3.298

6.  Consumption of dietary supplements to support weight reduction in adults according to sociodemographic background, body mass index, waist-hip ratio, body fat and physical activity.

Authors:  Adrian Lubowiecki-Vikuk; Magdalena Król-Zielińska; Adam Kantanista
Journal:  J Health Popul Nutr       Date:  2019-11-05       Impact factor: 2.000

Review 7.  Glutamate Neurotoxicity and Destruction of the Blood-Brain Barrier: Key Pathways for the Development of Neuropsychiatric Consequences of TBI and Their Potential Treatment Strategies.

Authors:  Benjamin F Gruenbaum; Alexander Zlotnik; Ilya Fleidervish; Amit Frenkel; Matthew Boyko
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

8.  Comparison of new forms of creatine in raising plasma creatine levels.

Authors:  Ralf Jäger; Roger C Harris; Martin Purpura; Marc Francaux
Journal:  J Int Soc Sports Nutr       Date:  2007-11-12       Impact factor: 5.150

Review 9.  Regulation of pyruvate metabolism and human disease.

Authors:  Lawrence R Gray; Sean C Tompkins; Eric B Taylor
Journal:  Cell Mol Life Sci       Date:  2013-12-21       Impact factor: 9.261

10.  Targeting Host Glycolysis as a Strategy for Antimalarial Development.

Authors:  Andrew J Jezewski; Yu-Hsi Lin; Julie A Reisz; Rachel Culp-Hill; Yasaman Barekatain; Victoria C Yan; Angelo D'Alessandro; Florian L Muller; Audrey R Odom John
Journal:  Front Cell Infect Microbiol       Date:  2021-09-16       Impact factor: 6.073

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.